Topic: ALFASIGMA
3 results were found.
Alfasigma to acquire Intercept Pharma - September 28, 2023
Alfasigma to acquire the entire share capital of Sofar - August 2, 2022
Alfasigma acquires European license for bentracimab from PhaseBio for up to $245 million - June 22, 2021